Brief Description
Correlia Biosystems develops streamlined assay platforms to reduce the time and cost for quantifying proteins for proteomic and pharmaceutical applications. Our research instruments provide multiplexing capabilities for large protein panels including cytokines and post-translational modifications with unparalleled speed and automation. The company is dedicated to reducing the cost and time to market for candidate drug compounds, and facilitating the access of researchers to large panel protein studies. The company's biomeasurement technology serves the world's top 20 pharmaceutical companies.
The company was founded to commercialize a novel protein immobilization technique invented in the lab of UC Berkeley Assistant Professor of Bioengineering Amy Herr, in collaboration with Novartis Diagnostics. Co-founder Muhammet Kursad Araz was a postdoc, and co-founders Adwasi Apori and Samuel Tia earned their PhDs, in Dr. Herr's lab. Correlia Biosystems joined the CITRIS Foundry, the in-house incubator of the multicampus CITRIS and the Banatao Institute headquartered at UC Berkeley, worked at the QB3@953 startup incubator in San Francisco, and participated in UCSF I-Corps Lean Launchpad.
Timeline
- 2013. Company founded
Inventors
Akwasi Apori, Muhammet Araz, Amy Herr